Role of interleukin-6 in cancer progression and therapeutic resistance
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of interleukin-6 in cancer progression and therapeutic resistance
Authors
Keywords
IL-6, Cancer, Therapeutic resistance, STAT-3, Chemotherapy, Radio-resistance
Journal
TUMOR BIOLOGY
Volume 37, Issue 9, Pages 11553-11572
Publisher
Springer Nature
Online
2016-06-03
DOI
10.1007/s13277-016-5098-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade
- (2016) Alexandra Eichten et al. CANCER RESEARCH
- Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells
- (2015) Anant Narayan Bhatt et al. BMC CANCER
- New horizons in tumor microenvironment biology: challenges and opportunities
- (2015) Fei Chen et al. BMC Medicine
- Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells
- (2015) M Ricciardi et al. BRITISH JOURNAL OF CANCER
- Sorafenib Treatment of Advanced Renal Cell Carcinoma Patients in Daily Practice: The Large International PREDICT Study
- (2015) D. Jäger et al. Clinical Genitourinary Cancer
- AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer
- (2015) Aya Kobayashi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome
- (2015) Qing Wei et al. LABORATORY INVESTIGATION
- Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels
- (2015) Tomofumi Miura et al. PANCREAS
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells
- (2015) Minghua Zou et al. CELLULAR ONCOLOGY
- Siltuximab (CNTO 328): a promising option for human malignancies
- (2015) Bao-An Chen et al. Drug Design Development and Therapy
- Stress-related hormone norepinephrine induces interleukin-6 expression in GES-1 cells
- (2015) R. Yang et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer
- (2015) Aki Isobe et al. PLoS One
- Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
- (2015) Xiaokui Yu et al. PLoS One
- Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner
- (2014) Heyang Xu et al. BMC CANCER
- Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3
- (2014) S A A Patel et al. BRITISH JOURNAL OF CANCER
- Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis
- (2014) Tania Valencia et al. CANCER CELL
- Interleukin-6 and its receptors: A highly regulated and dynamic system
- (2014) Janina Wolf et al. CYTOKINE
- Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
- (2014) Lanxi Song et al. Journal of Thoracic Oncology
- Siltuximab in transplant-ineligible patients with myeloma
- (2014) Sanjeet Bagcchi LANCET ONCOLOGY
- Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo
- (2014) Louise M. Judd et al. PLoS One
- Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer
- (2014) Katsutoshi Ando et al. PLoS One
- The two faces of IL-6 in the tumor microenvironment
- (2014) Daniel T. Fisher et al. SEMINARS IN IMMUNOLOGY
- Interleukin-6 is required for cell cycle arrest and activation of DNA repair enzymes after partial hepatectomy in mice
- (2014) Shingo Tachibana et al. Cell and Bioscience
- Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy
- (2014) Osamu Shibayama et al. Cancer Medicine
- Chronic Inflammation and Cytokines in the Tumor Microenvironment
- (2014) Glauben Landskron et al. Journal of Immunology Research
- Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
- (2014) Ailian Xiong et al. Cancers
- Interleukin-6 at discharge predicts all-cause mortality in patients with sepsis
- (2013) Mohammad Naffaa et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK
- (2013) James P. White et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The role of intratumoral and systemic IL-6 in breast cancer
- (2013) Christine Dethlefsen et al. BREAST CANCER RESEARCH AND TREATMENT
- Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
- (2013) T Nagasaki et al. BRITISH JOURNAL OF CANCER
- Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
- (2013) Seog-Young Kim et al. CELLULAR SIGNALLING
- Interleukin-6: Possible biological roles during exercise
- (2013) Dace Reihmane et al. European Journal of Sport Science
- Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?
- (2013) Pura Muñoz-Cánoves et al. FEBS Journal
- The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications—a review
- (2013) Antonio Macciò et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model
- (2013) Cyril Touboul et al. Journal of Translational Medicine
- IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
- (2013) Miao-Fen Chen et al. Molecular Cancer
- IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer
- (2013) Miao-Fen Chen et al. PLoS One
- The role of IL-6 in the radiation response of prostate cancer
- (2013) Chun-Te Wu et al. Radiation Oncology
- Chromosomal Instability Triggered by Rrm2b Loss Leads to IL-6 Secretion and Plasmacytic Neoplasms
- (2013) Lufen Chang et al. Cell Reports
- Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutase
- (2012) Charles O. Brown et al. BIOCHEMICAL JOURNAL
- Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia
- (2012) A. Eghtedar et al. BLOOD
- Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer
- (2012) N Kozakai et al. BRITISH JOURNAL OF CANCER
- DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors
- (2012) Un Jung Yun et al. CANCER LETTERS
- Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
- (2012) J. B. Mitchem et al. CANCER RESEARCH
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Interleukin 6 protects H2O2-induced cardiomyocytes injury through upregulation of prohibitin via STAT3 phosphorylation
- (2012) Yuhua Jia et al. CELL BIOCHEMISTRY AND FUNCTION
- Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease
- (2012) Apostolos Kontzias et al. CURRENT OPINION IN PHARMACOLOGY
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Interleukin-6 - A Key Regulator of Colorectal Cancer Development
- (2012) Maximilian J. Waldner et al. International Journal of Biological Sciences
- Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
- (2012) Chin Hao Chang et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Interleukin-6 in the Radiation Response of Liver Tumors
- (2012) Miao-Fen Chen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-Induced Colorectal Cancer
- (2012) M. M. Seavey et al. MOLECULAR CANCER THERAPEUTICS
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma
- (2012) D Kesanakurti et al. ONCOGENE
- Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
- (2011) S. I. Grivennikov et al. ANNALS OF THE RHEUMATIC DISEASES
- Cancer-associated adipocytes promotes breast tumor radioresistance
- (2011) Ludivine Bochet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
- (2011) Piyush B. Gupta et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- IL-6/IL-6 receptor system and its role in physiological and pathological conditions
- (2011) Masahiko Mihara et al. CLINICAL SCIENCE
- Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model*
- (2011) Tanja Barkhausen et al. CRITICAL CARE MEDICINE
- Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
- (2011) Toshio Tanaka et al. FEBS LETTERS
- Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11bhighGr1low macrophages
- (2011) Gabriela Schiechl et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of JAK2 Signaling by TG101209 Enhances Radiotherapy in Lung Cancer Models
- (2011) Yunguang Sun et al. Journal of Thoracic Oncology
- Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
- (2011) Zoran Culig et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- NF-κB and STAT3 cooperatively induce IL6 in starved cancer cells
- (2011) S Yoon et al. ONCOGENE
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
- (2011) S Hart et al. Blood Cancer Journal
- Zoledronic acid in breast cancer: latest findings and interpretations
- (2011) Michael Gnant Therapeutic Advances in Medical Oncology
- TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells
- (2010) Vijay Ramakrishnan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Targeting inflammatory pathways for tumor radiosensitization
- (2010) Amit Deorukhkar et al. BIOCHEMICAL PHARMACOLOGY
- JSI-124 inhibits glioblastoma multiforme cell proliferation through G2/M cell cycle arrest and apoptosis augmentation
- (2010) Yuhang Su et al. CANCER BIOLOGY & THERAPY
- DNA Damage-Mediated Induction of a Chemoresistant Niche
- (2010) Luke A. Gilbert et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action
- (2010) F. Thomas Wunderlich et al. Cell Metabolism
- The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
- (2010) Athena Chalaris et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Clinical overview of sorafenib in breast cancer
- (2010) Alvaro Moreno-Aspitia Future Oncology
- IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines
- (2010) Wiltrud Lederle et al. INTERNATIONAL JOURNAL OF CANCER
- Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells
- (2010) Jacqueline A. Gasche et al. INTERNATIONAL JOURNAL OF CANCER
- Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation
- (2010) Simone Radtke et al. JOURNAL OF CELL SCIENCE
- Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro
- (2010) Chen Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor
- (2010) M. M. McFarland-Mancini et al. JOURNAL OF IMMUNOLOGY
- Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3
- (2010) Fan Yang et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Constitutive Activation of STAT3 by Curcurbitacin-I (JSI-124) Sensitized Human B-Leukemia Cells to Apoptosis
- (2010) G. Ishdorj et al. MOLECULAR CANCER THERAPEUTICS
- ATM- and NEMO-Dependent ELKS Ubiquitination Coordinates TAK1-Mediated IKK Activation in Response to Genotoxic Stress
- (2010) Zhao-Hui Wu et al. MOLECULAR CELL
- Interleukin 6 Enhances Glycolysis through Expression of the Glycolytic Enzymes Hexokinase 2 and 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase-3
- (2010) Masaru Ando et al. JOURNAL OF NIPPON MEDICAL SCHOOL
- IL-6 Protects against Hyperoxia-Induced Mitochondrial Damage via Bcl-2–Induced Bak Interactions with Mitofusions
- (2009) Aaron B. Waxman et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
- (2009) Dimitrios Iliopoulos et al. CELL
- Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma
- (2009) S. Shinriki et al. CLINICAL CANCER RESEARCH
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
- (2009) Francis Rodier et al. NATURE CELL BIOLOGY
- Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
- (2008) Sergei Grivennikov et al. CANCER CELL
- NF-κB and cancer—identifying targets and mechanisms
- (2008) Willscott E Naugler et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
- (2008) Maciej Kujawski et al. JOURNAL OF CLINICAL INVESTIGATION
- Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to Therapy
- (2008) Kathleen M. Woods Ignatoski et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Serum Concentration of Interleukin-6 Is Increased Both in Active and Remission Stages of Pemphigus Vulgaris
- (2008) Joanna Narbutt et al. MEDIATORS OF INFLAMMATION
- Interleukin-6 and Neural Stem Cells: More Than Gliogenesis
- (2008) Omedul Islam et al. MOLECULAR BIOLOGY OF THE CELL
- p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
- (2008) Keiko Kawauchi et al. NATURE CELL BIOLOGY
- Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance
- (2008) S J Veuger et al. ONCOGENE
- Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines
- (2008) Layka A. Asbagh et al. International Braz J Urol
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started